diet online
diet pills online
diet and diet pills
All Diet News
diet pill Acomplia - online guide Diet Pills, acomplia

Weight loss is perhaps the most talked topic of late. Its not only considered as a problem but medical science mark it as an epidemic. It’s a nutritional disorder that arises due to over consumption of fats then our body requires. The new diet pill Acomplia is generating great interest among the overweight patients on this pretext. Proven records are also available related to its success on obesity.

Though, studies on the side-effects of Acomplia have been done, but are clinically proved to be tolerable and mild. Dizziness nausea, stomach upset, depression and sweating are a few to mention. Though reports of overdose haven’t been proved till date, but better to discard the practice, for it may be proved harmful sometimes.

Usualy a dose of 20mg before breakfast or in an empty stomach is enough. But a mixture of a controlled diet, some exercise and Acomplia can really give miraculous results. According to clinical trials a person can loose his or her body weight, any amount 20-25 pound if a dose of 20mg is practised for a period of a year.

Although promising results are proved, it is should be used under a good dietician’s observation. Often there are misconception among it’s users that an overdose or double dose of Acomplia will show faster results. But one should know the fact it’s a drug and trying to overdose it can prove to be fatal

Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug.

Studies shown that it increases levels of HDL (good cholesterol) while at the same time reducing the triglycerides (bad cholesterol). Acomplia was also found to reduce the risk of regaining weight. When a group of patients from one of the clinical trials was randomized and split into Acomplia and placebo groups, those patients who continued on Acomplia achieved a total weight loss of 16.57 pound over the two year trial period. On the other hand patients who were transferred to placebo achieved a much lower weight loss of only 6.85 pound kg over the same period.
And much more: there are nerve receptors called CB1receptors that exist in the brain and fat cells. These receptors urge the body to overeat and smoke. Acomplia works by targeting the CBI receptors and blocking the body's ability to receive signals that tells it to smoke or eat more. It helps to normalize the EndoCannabinoid System thus making hunger and cigarette cravings more manageable. This blocking of signals results in weight loss. It further improves the cardiovascular or metabolic risk factors in obese people and reduces their dependence on nicotine and helps them quit smoking.

Brand names: Acomplia, Rimonabant, Zimulti

Is The new age diet pill developed by world’s third largest French Pharmaceutical Company. This diet pill was officially approved in Britain on June 28th 2006. It has also be approved in several other European countries and other countries around the world. Which could someday lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market. And it recently did not approve it for the USA. Acomplia diet pill offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication obviously does not come without some potential side effects for its user but could offer more that others weight loss drugs such as phentermine.

buy ACOMPLIA online

 

 
In order to have full access to our resources you must register!
#1 Name: j_nhiggins (24 September 2007 23:39)
How much weight can I lose by taking Acomplia month?
#2 Name: diet-pill (25 September 2007 17:30)
Clinical trials conducted with Acomplia on more than 6800 patients swow substantial results. Patients given Acomplia for a period of one year achieved an average weight loss of fourteen and half pound. Most of the weight loss was achieved in the first 9 months of the trial with Acomplia.


--------------------
Addition of the comment